Neither source provides structured incidence for vaginal dryness, vulvovaginitis, BV, dyspareunia, discharge changes, or atrophy
During shortages of Wegovy, Ozempic, Mounjaro, and Zepbound, the FDA exercised temporary enforcement discretion , allowing compounding pharmacies to help meet patient demand. Once manufacturing stabilized: Semaglutide injection products were removed from the FDA Drug Shortage List Tirzepatide injection products were formally declared resolved Compounding reverted to pre-shortage federal and state limits Broad, shortage-based compounding is no longer allowed in 2026
and Eli Lilly, the maker of Mounjaro and Zepbound
Pancreatitis Seek urgent medical help if you have abdominal pain
At Regency Medical Spa & Hair Clinic, our experienced team will monitor your progress and adjust your treatment plan as needed to maximize benefits while minimizing side effects